Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers:
SEC Accession No. 0001193125-26-006262
Filing Date
2026-01-07
Accepted
2026-01-07 16:01:45
Documents
20
Effectiveness Date
2026-01-07

Document Format Files

Seq Description Document Type Size
1 S-3ASR d12465ds3asr.htm S-3ASR 342109
2 EX-4.7 d12465dex47.htm EX-4.7 290288
3 EX-5.1 d12465dex51.htm EX-5.1 23128
4 EX-5.2 d12465dex52.htm EX-5.2 11446
5 EX-23.1 d12465dex231.htm EX-23.1 1977
6 EX-FILING FEES d12465dexfilingfees.htm   iXBRL EX-FILING FEES 32814
7 GRAPHIC g12465dsp01.jpg GRAPHIC 4635
8 GRAPHIC g12465dsp02.jpg GRAPHIC 3252
9 GRAPHIC g12465g00n04.jpg GRAPHIC 79331
10 GRAPHIC g12465g00n33.jpg GRAPHIC 78402
  Complete submission text file 0001193125-26-006262.txt   1088568

Data Files

Seq Description Document Type Size
22 EXTRACTED XBRL INSTANCE DOCUMENT d12465dexfilingfees_htm.xml XML 14754
Mailing Address 100 CAMPUS DRIVE, SUITE 102 FLORHAM PARK NJ 07932
Business Address 100 CAMPUS DRIVE, SUITE 102 FLORHAM PARK NJ 07932 (877) 742-8466
Phathom Pharmaceuticals, Inc. (Filer) CIK: 0001783183 (see all company filings)

EIN.: 824151574 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3ASR | Act: 33 | File No.: 333-292596 | Film No.: 26515637
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)